---
figid: PMC7916193__biomedicines-09-00171-g006
figlink: pmc/articles/PMC7916193/figure/biomedicines-09-00171-f006/
number: Figure 6
caption: Pathways involved in cutaneous squamous cell carcinoma (cSCC) pathogenesis.
  Molecular alterations, which drive cSCC development, have been identified in pathways
  involved in cell cycle regulation, apoptosis, senescence, differentiation, and mitogenic/survival.
  (A) The tumor suppressor genes p16INK4A and p14ARF control retinoblastoma (pRb)
  and p53 pathways, respectively. Their loss of function promotes cell cycle counteracting
  senescence or apoptosis. Aberrant activation of E2F transcription can also be due
  to cyclin D activation or pRb expression loss. pRb and p53 inactivation is also
  mediated by E6 and E7 (red hexagons) human papilloma virus (HPV) proteins. (B) EGF-R
  aberrant activation, p53 inactivation, or NOTCH gene mutations inactivate the NOTCH
  pathway. Inactivation of NOTCH abolishes the direct or IRF6-mediated suppression
  of ΔNp63, favoring proliferation, survival, and stemness. NOTCH inactivation also
  counteracts senescence and apoptosis mediated by its targets (HES1 and p21). Moreover,
  ΔNp63 upregulation represses the expression of HES1, p21, and p16INK4A. (C) RAS-RAF-MEK-ERK
  and PI3K/AKT/mTOR pathways share the up-stream proteins, such as tyrosine kinase
  receptors (RTK) and RAS. Activating mutations in RTK, RAS or inactivation of negative
  regulator RASA1 promotes cell proliferation and survival through constitutive activation
  of both pathways. Aberrant activation of these pathways can also derive by B-RAF
  or PI3K/AKT activation, or Phosphatase and tensin homolog (PTEN) inactivation. The
  RTKs and the downstream pathways can be targeted with several drugs (blue hexagons)
  to inhibit cSCC progression. However, both pathways can be activated by RAS mutations,
  present in photodamaged skin, as part of a compensatory mechanism that could drive
  resistance to therapeutic targeting strategies. Proteins with commonly accepted
  tumor promoting and suppressing functions are highlighted in orange and green, respectively.
  Activated or downregulated processes (circles, squares and arrows) are highlighted
  in dark orange and green, respectively. Block and dash arrows indicate direct or
  indirect interactions, respectively.
pmcid: PMC7916193
papertitle: 'Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic
  Approaches.'
reftext: Luca Fania, et al. Biomedicines. 2021 Feb;9(2):171.
pmc_ranked_result_index: '114165'
pathway_score: 0.9581659
filename: biomedicines-09-00171-g006.jpg
figtitle: Pathways involved in cutaneous squamous cell carcinoma (cSCC) pathogenesis
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7916193__biomedicines-09-00171-g006.html
  '@type': Dataset
  description: Pathways involved in cutaneous squamous cell carcinoma (cSCC) pathogenesis.
    Molecular alterations, which drive cSCC development, have been identified in pathways
    involved in cell cycle regulation, apoptosis, senescence, differentiation, and
    mitogenic/survival. (A) The tumor suppressor genes p16INK4A and p14ARF control
    retinoblastoma (pRb) and p53 pathways, respectively. Their loss of function promotes
    cell cycle counteracting senescence or apoptosis. Aberrant activation of E2F transcription
    can also be due to cyclin D activation or pRb expression loss. pRb and p53 inactivation
    is also mediated by E6 and E7 (red hexagons) human papilloma virus (HPV) proteins.
    (B) EGF-R aberrant activation, p53 inactivation, or NOTCH gene mutations inactivate
    the NOTCH pathway. Inactivation of NOTCH abolishes the direct or IRF6-mediated
    suppression of ΔNp63, favoring proliferation, survival, and stemness. NOTCH inactivation
    also counteracts senescence and apoptosis mediated by its targets (HES1 and p21).
    Moreover, ΔNp63 upregulation represses the expression of HES1, p21, and p16INK4A.
    (C) RAS-RAF-MEK-ERK and PI3K/AKT/mTOR pathways share the up-stream proteins, such
    as tyrosine kinase receptors (RTK) and RAS. Activating mutations in RTK, RAS or
    inactivation of negative regulator RASA1 promotes cell proliferation and survival
    through constitutive activation of both pathways. Aberrant activation of these
    pathways can also derive by B-RAF or PI3K/AKT activation, or Phosphatase and tensin
    homolog (PTEN) inactivation. The RTKs and the downstream pathways can be targeted
    with several drugs (blue hexagons) to inhibit cSCC progression. However, both
    pathways can be activated by RAS mutations, present in photodamaged skin, as part
    of a compensatory mechanism that could drive resistance to therapeutic targeting
    strategies. Proteins with commonly accepted tumor promoting and suppressing functions
    are highlighted in orange and green, respectively. Activated or downregulated
    processes (circles, squares and arrows) are highlighted in dark orange and green,
    respectively. Block and dash arrows indicate direct or indirect interactions,
    respectively.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - TP53
  - CDK4
  - CDK6
  - MDM2
  - E2F3
  - E2F8
  - E2F1
  - E2F2
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - IRF6
  - CERS1
  - HES1
  - PTEN
  - PLP2
  - GRB2
  - SOS1
  - SOS2
  - PDK1
  - PDK2
  - PDK3
  - PDK4
  - HRAS
  - KRAS
  - NRAS
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - RASA1
  - ARAF
  - BRAF
  - RAF1
  - AKT2
  - AKT3
  - AKT1
  - MAP2K1
  - MAP2K2
  - MTOR
  - MAPK3
  - MAPK1
  - GTP
  - GDP
  - Stemness
genes:
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: р53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: CDK4/6
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: CDK4/6
  symbol: CDK6
  source: hgnc_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: HDM2
  symbol: HDM2
  source: hgnc_alias_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F3
  entrez: '1871'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F8
  entrez: '79733'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F1
  entrez: '1869'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F2
  entrez: '1870'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F4
  entrez: '1874'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F5
  entrez: '1875'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F6
  entrez: '1876'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F7
  entrez: '144455'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: IRF6
  symbol: IRF6
  source: hgnc_symbol
  hgnc_symbol: IRF6
  entrez: '3664'
- word: IAG1
  symbol: LAG1
  source: hgnc_alias_symbol
  hgnc_symbol: CERS1
  entrez: '10715'
- word: HES1
  symbol: HES1
  source: hgnc_symbol
  hgnc_symbol: HES1
  entrez: '3280'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F3
  entrez: '1871'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F8
  entrez: '79733'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F1
  entrez: '1869'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F2
  entrez: '1870'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F4
  entrez: '1874'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F5
  entrez: '1875'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F6
  entrez: '1876'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F7
  entrez: '144455'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PIP2
  symbol: PLP2
  source: hgnc_symbol
  hgnc_symbol: PLP2
  entrez: '5355'
- word: GRB2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK2
  entrez: '5164'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK3
  entrez: '5165'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK4
  entrez: '5166'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: RASA-1
  symbol: RASA1
  source: hgnc_symbol
  hgnc_symbol: RASA1
  entrez: '5921'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: B-RAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: МЕК1
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: RAF/MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: RAF/MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: RAF/MEK
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF/MEK
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF/MEK
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
chemicals:
- word: GTP
  source: MESH
  identifier: D006160
- word: GDP
  source: MESH
  identifier: D006153
diseases:
- word: Stemness
  source: MESH
  identifier: D020295
---
